Home > Financial Ratios > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Working Capital/Sales

    Back to All Ratios
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
   Working Capital/Sales(x) 2.211.573.273.576.67

What is the latest Working Capital/Sales ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Working Capital/Sales ratio of SYNCOM FORMULATIONS (INDIA) is 2.21 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20252.21
Mar20241.57
Mar20233.27
Mar20223.57
Mar20176.67

How is Working Capital/Sales of SYNCOM FORMULATIONS (INDIA) Trending?

Years Working Capital/Sales % Change
Mar2025 2.21
40.76
Mar2024 1.57
-51.99
Mar2023 3.27
-8.40
Mar2022 3.57
-46.48
Mar2017 6.67 -

Other Financial Ratios of SYNCOM FORMULATIONS (INDIA)


Compare Working Capital/Sales ratio of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,377.1 Cr -1.9% -10.6% -32% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,705.0 Cr -0.7% 2% -1.7% Stock Analytics
DIVIS LABORATORIES ₹167,091.0 Cr -2.1% -2.8% 7.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹127,555.0 Cr -0.9% -0.6% 12.2% Stock Analytics
CIPLA ₹120,919.0 Cr -1% -1.2% 3.6% Stock Analytics
DR REDDYS LABORATORIES ₹106,165.0 Cr -0.1% 2.3% 2.6% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-1.9%

-10.6%

-32%

SENSEX

0.2%

-0.5%

4%


You may also like the below Video Courses